Aggregated China Business Blogs



Sunway and Genzyme to Collaborate on Gene Therapy

Aggregated Source: Seeking Alpha China stocks
October 26, 2007|

Sunway Biotech Co. Ltd. of Shanghai will collaborate with Genzyme (NSDQ: GENZ) on the experimental gene therapy drug Ad2/HIF-1a, a drug that seeks to grow new blood vessels in patients with peripheral arterial disease. Sunway will manufacture the drug in China and undertake the trials necessary to win marketing approval in China from the SFDA. Genzyme is already testing Ad2/HIF-1a in Phase II trials in the US and Europe.



Original URL: Click here to visit original article
Copyright Seeking Alpha China stocks
Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • China’s Gene Therapy Cancer Drugs: Slow Acceptance of Great Science
  • Gene Therapy and Anti-Aging Treatments on Top of China Biopharma Agenda
  • Benda Pharmaceutical Developing Potential AIDS Vaccine
  • 3 Reasons Why Benda Pharmaceutical's Share Price Is Depressed
  • Benda's Jiangling Plant Receives Production Approval

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |